Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis—enhancing properties of psoriatic serum
- 30 September 1985
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 13 (3), 437-443
- https://doi.org/10.1016/s0190-9622(85)70186-7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Polymorphonuclear Leukocyte Function in Psoriasis: Chemotaxis, Chemokinesis, Beta-Adrenergic Receptors, and Proteolytic Enzymes of Polymorphonuclear Leukocytes in the Peripheral Blood from Psoriatic PatientsJournal of Investigative Dermatology, 1983
- Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulationBritish Journal of Dermatology, 1983
- The effects of retinoids on neutrophil functions in vitroJournal of the American Academy of Dermatology, 1982
- IgA-associated Inhibition of Polymorphonuclear Leukocyte Chemotaxis in Neutrophilic DermatosesJournal of Investigative Dermatology, 1981
- Increased Superoxide Generation by Normal Granulocytes Incubated In Sera from Patients with PsoriasisJournal of Investigative Dermatology, 1981
- Polymorphonuclear leukocyte chemotaxis in psoriasis: enhancement by self-activated serumBritish Journal of Dermatology, 1980
- Increased chemotactic activity of neutrophil leukocytes in psoriasisBritish Journal of Dermatology, 1980
- Psoriasis, Polymorphonuclear Leukocytes, and Lithium CarbonateArchives of Dermatology, 1979
- Enhanced Chemotactic and Phagocytic Activities of Leukocytes in Psoriasis VulgarisJournal of Investigative Dermatology, 1978
- Structural aspects of initial psoriatic lesionsArchives of Dermatological Research, 1974